Proud Member of EARA
INterview with Barlavento
💊 Sea4Us has now reached a historic milestone: It has completed pre-clinical safety and efficacy testing of its innovative analgesic S#072, a new non-opioid chemical entity intended for the treatment of severe chronic pain. The studies demonstrated high efficacy, exceptional safety, and an absence of relevant adverse effects, paving the way for the start of human clinical trials in 2026.
From the sea off Sagres, Sea4Us shows how the Algarve contributes to globally impactful medical solutions.
👉 You can read the full Barlavento piece here!
